サマリー

HDAC（ヒストン脱アセチル化酵素）阻害剤の世界市場 2023-2027
Technavioは、HDAC（ヒストンデアセチラーゼ）阻害剤市場をモニターしており、2022年から2027年の間に1億7261万ドル、予測期間中のCAGRは7.73%で加速すると予測しています。当レポートでは、HDAC（ヒストンデアセチラーゼ）阻害剤市場について、全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、高い標的親和性と特異性、腫瘍の適応症の高い普及率、新しいドラッグデリバリーシステムと併用療法の開発によって牽引されています。
TechnavioのHDAC（ヒストンデアセチラーゼ）阻害剤市場は以下のようにセグメント化されています：
投与経路別
- 経口HDAC阻害剤
- 非経口HDAC阻害剤
流通チャネル別
- 病院内薬局
- 小売薬局
- オンライン薬局
- その他
ジオグラフィー別
- 北アメリカ
- ヨーロッパ
- 亜細亜
- レスト・オブ・ワールド（ROW）
本調査では、今後数年間におけるHDAC（ヒストンデアセチラーゼ）阻害剤市場の成長を促進する主な理由の一つとして、老年人口の増加を挙げています。また、研究助成金や資金提供、がんに対する意識の高まりが、市場の大きな需要につながるとしています。
Technavioは、主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。当レポートでは、HDAC（ヒストンデアセチラーゼ）阻害剤市場について、以下の分野を取り上げています：
- HDAC（ヒストン脱アセチル化酵素）阻害剤市場のサイジング
- HDAC（ヒストン脱アセチル化酵素）阻害剤市場予測
- HDAC（ヒストンデアセチラーゼ）阻害剤市場の産業分析
Technavioの強固なベンダー分析は、クライアントが市場での地位を向上させることを目的としており、これに沿って本レポートでは、Acrotech Biopharma Inc.を含むHDAC（ヒストン脱アセチル化酵素）阻害剤市場の主要ベンダー数社の詳細分析を提供しています、AstraZeneca社、Bio Techne社、BioVision社、Bristol Myers Squibb社、Celleron Therapeutics社、Curis社、Huya Bioscience International LLC、InvivoGen社、Italfarmaco Spa、Medivir AB、Merck and Co.Inc.、Novartis AG、Onxeo SA、Shenzhen Chipscreen Biotechnology Co.Ltd.、Syndax Pharmaceuticals Inc.、東京化成工業 Co.Ltd.、Viracta Therapeutics Inc.、Xynomic Pharmaceuticals (Nanjing) Co. Ltd.、Cetya Therapeutics Inc.などです。また、HDAC（ヒストンデアセチラーゼ）阻害剤市場の分析レポートには、今後の動向や市場成長に影響を与える課題についての情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/hdac-histone-deacetylase-inhibitors-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。また、業界の主要なインフルエンサーを特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global HDAC (histone deacetylase) inhibitors market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global HDAC (histone deacetylase) inhibitors market 2017 - 2021 ($ million)
o 4.2 Route of administration Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Route of administration Segment 2017 - 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Route of Administration
o 6.1 Market segments
o Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
o 6.2 Comparison by Route of Administration
o Exhibit 32: Chart on Comparison by Route of Administration
o Exhibit 33: Data Table on Comparison by Route of Administration
o 6.3 Oral HDAC inhibitors - Market size and forecast 2022-2027
o Exhibit 34: Chart on Oral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Oral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Oral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
o 6.4 Parenteral HDAC inhibitors - Market size and forecast 2022-2027
o Exhibit 38: Chart on Parenteral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Parenteral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Parenteral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Parenteral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Route of Administration
o Exhibit 42: Market opportunity by Route of Administration ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 43: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 44: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 45: Chart on Comparison by Distribution Channel
o Exhibit 46: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacies - Market size and forecast 2022-2027
o Exhibit 47: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
o 7.4 Retail pharmacies - Market size and forecast 2022-2027
o Exhibit 51: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
o 7.5 Online pharmacies - Market size and forecast 2022-2027
o Exhibit 55: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
o 7.6 Others - Market size and forecast 2022-2027
o Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Distribution Channel
o Exhibit 63: Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 65: Chart on Market share by geography 2022-2027 (%)
o Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 67: Chart on Geographic comparison
o Exhibit 68: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Canada - Market size and forecast 2022-2027
o Exhibit 89: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 Germany - Market size and forecast 2022-2027
o Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 105: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 106: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 108: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 109: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 110: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 111: Matrix on vendor position and classification
o 12.3 Acrotech Biopharma Inc.
o Exhibit 112: Acrotech Biopharma Inc. - Overview
o Exhibit 113: Acrotech Biopharma Inc. - Product / Service
o Exhibit 114: Acrotech Biopharma Inc. - Key offerings
o 12.4 AstraZeneca Plc
o Exhibit 115: AstraZeneca Plc - Overview
o Exhibit 116: AstraZeneca Plc - Product / Service
o Exhibit 117: AstraZeneca Plc - Key news
o Exhibit 118: AstraZeneca Plc - Key offerings
o 12.5 Bristol Myers Squibb Co.
o Exhibit 119: Bristol Myers Squibb Co. - Overview
o Exhibit 120: Bristol Myers Squibb Co. - Product / Service
o Exhibit 121: Bristol Myers Squibb Co. - Key news
o Exhibit 122: Bristol Myers Squibb Co. - Key offerings
o 12.6 Celleron Therapeutics Ltd.
o Exhibit 123: Celleron Therapeutics Ltd. - Overview
o Exhibit 124: Celleron Therapeutics Ltd. - Key offerings
o 12.7 Curis Inc.
o Exhibit 125: Curis Inc. - Overview
o Exhibit 126: Curis Inc. - Product / Service
o Exhibit 127: Curis Inc. - Key offerings
o 12.8 Huya Bioscience International LLC
o Exhibit 128: Huya Bioscience International LLC - Overview
o Exhibit 129: Huya Bioscience International LLC - Product / Service
o Exhibit 130: Huya Bioscience International LLC - Key offerings
o 12.9 Italfarmaco Spa
o Exhibit 131: Italfarmaco Spa - Overview
o Exhibit 132: Italfarmaco Spa - Product / Service
o Exhibit 133: Italfarmaco Spa - Key offerings
o 12.10 Medivir AB
o Exhibit 134: Medivir AB - Overview
o Exhibit 135: Medivir AB - Product / Service
o Exhibit 136: Medivir AB - Key offerings
o 12.11 Merck and Co. Inc.
o Exhibit 137: Merck and Co. Inc. - Overview
o Exhibit 138: Merck and Co. Inc. - Business segments
o Exhibit 139: Merck and Co. Inc. - Key news
o Exhibit 140: Merck and Co. Inc. - Key offerings
o Exhibit 141: Merck and Co. Inc. - Segment focus
o 12.12 Novartis AG
o Exhibit 142: Novartis AG - Overview
o Exhibit 143: Novartis AG - Business segments
o Exhibit 144: Novartis AG - Key offerings
o Exhibit 145: Novartis AG - Segment focus
o 12.13 Onxeo SA
o Exhibit 146: Onxeo SA - Overview
o Exhibit 147: Onxeo SA - Product / Service
o Exhibit 148: Onxeo SA - Key offerings
o 12.14 Shenzhen Chipscreen Biotechnology Co. Ltd.
o Exhibit 149: Shenzhen Chipscreen Biotechnology Co. Ltd. - Overview
o Exhibit 150: Shenzhen Chipscreen Biotechnology Co. Ltd. - Product / Service
o Exhibit 151: Shenzhen Chipscreen Biotechnology Co. Ltd. - Key offerings
o 12.15 Syndax Pharmaceuticals Inc.
o Exhibit 152: Syndax Pharmaceuticals Inc. - Overview
o Exhibit 153: Syndax Pharmaceuticals Inc. - Key offerings
o 12.16 Viracta Therapeutics Inc.
o Exhibit 154: Viracta Therapeutics Inc. - Overview
o Exhibit 155: Viracta Therapeutics Inc. - Product / Service
o Exhibit 156: Viracta Therapeutics Inc. - Key offerings
o 12.17 Xynomic Pharmaceuticals (Nanjing) Co. Ltd.
o Exhibit 157: Xynomic Pharmaceuticals (Nanjing) Co. Ltd. - Overview
o Exhibit 158: Xynomic Pharmaceuticals (Nanjing) Co. Ltd. - Product / Service
o Exhibit 159: Xynomic Pharmaceuticals (Nanjing) Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 160: Inclusions checklist
o Exhibit 161: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 162: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 163: Research methodology
o Exhibit 164: Validation techniques employed for market sizing
o Exhibit 165: Information sources
o 13.5 List of abbreviations
o Exhibit 166: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global HDAC (histone deacetylase) inhibitors market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Route of administration Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Oral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Parenteral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Parenteral HDAC inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Parenteral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Parenteral HDAC inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Route of Administration ($ million)
Exhibits43: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits44: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Distribution Channel
Exhibits46: Data Table on Comparison by Distribution Channel
Exhibits47: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits63: Market opportunity by Distribution Channel ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share by geography 2022-2027 (%)
Exhibits66: Data Table on Market share by geography 2022-2027 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits105: Market opportunity by geography ($ million)
Exhibits106: Impact of drivers and challenges in 2022 and 2027
Exhibits107: Overview on Criticality of inputs and Factors of differentiation
Exhibits108: Overview on factors of disruption
Exhibits109: Impact of key risks on business
Exhibits110: Vendors covered
Exhibits111: Matrix on vendor position and classification
Exhibits112: Acrotech Biopharma Inc. - Overview
Exhibits113: Acrotech Biopharma Inc. - Product / Service
Exhibits114: Acrotech Biopharma Inc. - Key offerings
Exhibits115: AstraZeneca Plc - Overview
Exhibits116: AstraZeneca Plc - Product / Service
Exhibits117: AstraZeneca Plc - Key news
Exhibits118: AstraZeneca Plc - Key offerings
Exhibits119: Bristol Myers Squibb Co. - Overview
Exhibits120: Bristol Myers Squibb Co. - Product / Service
Exhibits121: Bristol Myers Squibb Co. - Key news
Exhibits122: Bristol Myers Squibb Co. - Key offerings
Exhibits123: Celleron Therapeutics Ltd. - Overview
Exhibits124: Celleron Therapeutics Ltd. - Key offerings
Exhibits125: Curis Inc. - Overview
Exhibits126: Curis Inc. - Product / Service
Exhibits127: Curis Inc. - Key offerings
Exhibits128: Huya Bioscience International LLC - Overview
Exhibits129: Huya Bioscience International LLC - Product / Service
Exhibits130: Huya Bioscience International LLC - Key offerings
Exhibits131: Italfarmaco Spa - Overview
Exhibits132: Italfarmaco Spa - Product / Service
Exhibits133: Italfarmaco Spa - Key offerings
Exhibits134: Medivir AB - Overview
Exhibits135: Medivir AB - Product / Service
Exhibits136: Medivir AB - Key offerings
Exhibits137: Merck and Co. Inc. - Overview
Exhibits138: Merck and Co. Inc. - Business segments
Exhibits139: Merck and Co. Inc. - Key news
Exhibits140: Merck and Co. Inc. - Key offerings
Exhibits141: Merck and Co. Inc. - Segment focus
Exhibits142: Novartis AG - Overview
Exhibits143: Novartis AG - Business segments
Exhibits144: Novartis AG - Key offerings
Exhibits145: Novartis AG - Segment focus
Exhibits146: Onxeo SA - Overview
Exhibits147: Onxeo SA - Product / Service
Exhibits148: Onxeo SA - Key offerings
Exhibits149: Shenzhen Chipscreen Biotechnology Co. Ltd. - Overview
Exhibits150: Shenzhen Chipscreen Biotechnology Co. Ltd. - Product / Service
Exhibits151: Shenzhen Chipscreen Biotechnology Co. Ltd. - Key offerings
Exhibits152: Syndax Pharmaceuticals Inc. - Overview
Exhibits153: Syndax Pharmaceuticals Inc. - Key offerings
Exhibits154: Viracta Therapeutics Inc. - Overview
Exhibits155: Viracta Therapeutics Inc. - Product / Service
Exhibits156: Viracta Therapeutics Inc. - Key offerings
Exhibits157: Xynomic Pharmaceuticals (Nanjing) Co. Ltd. - Overview
Exhibits158: Xynomic Pharmaceuticals (Nanjing) Co. Ltd. - Product / Service
Exhibits159: Xynomic Pharmaceuticals (Nanjing) Co. Ltd. - Key offerings
Exhibits160: Inclusions checklist
Exhibits161: Exclusions checklist
Exhibits162: Currency conversion rates for US$
Exhibits163: Research methodology
Exhibits164: Validation techniques employed for market sizing
Exhibits165: Information sources
Exhibits166: List of abbreviations